| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |